

Rabeprazole Sodium Domperidone Capsule
₹ 891/Box
| Composition | Rabeprazole 20mg and Domperidone 30mg, Rabeprazole 20mg and Domperidone 30mg |
| Dosage Form | Capsule |
| Pack Size | 10*10 Capsules |
| Packaging Type | Strips |
| Brand Name | DORAB-SR |
| Strength | 50 mg |
| Manufacturer | Apex Formulations Private Limited |
| Shelf Life | 24 Months |
| Usages/Application | To neutralize excessive acid in the stomach |
| Prescription/Non-Prescription | Prescription |
| Also Gives | Third Party Manufacturing, PCD Pharma Franchise |
| Manufactured By | Apex Formulations Private Limited |
| Brand | DORAB-SR |
| Packaging Type | Alu-Alu |
| Packaging Size | 10*10 Capsules |
| Country of Origin | Made in India |
Find related categories
Shipping Information
| Availability | In Stock |
| Price | Excluding all taxes |
| Ships from | Ahmedabad |
| Shipping | As per delivery location |
Product Image



About the Company
- GST Registration Year
- 2017
- Legal Status of Firm
- Limited Company
- Nature of Business
- Manufacturer
- Number of Employees
- 26 To 50 People
- Annual Turnover
- 25 - 100 Cr
- IndiaMART Member Since
- Feb 2016
- GST
- 24**********1ZR
- Import Export Code (IEC)
- *******414
Apex Formulation is Spearheaded by Director Mr. Vipul V Shah and second generation entrepreneur Mr. Ishan V Shah who has joined the company with Vision to expand its global foot print. The Company also features experienced and qualified staff looking after Production, Quality check, Packing, storage, marketing and Dispatch. Our corporate office in Ahmedabad includes a bunch of brilliant professionals who leverage their experience and expertise aligned with our objectives to the tee.Our business is driven by Quality, Integrity, Excellence & Care. We are specialised in manufacture of Anti-TB medicines covering wide range of products .
The firm runs in accordance to the Green initiative in employing and furtherance of sustainable energy with the use of solar equipment to enable minimum damage and maximizing co-existence with nature.





